Martin Proescholdt - Concepedia

Author

Martin Proescholdt

Also Known As

M A Proescholdt, M PROESCHOLDT, M Proescholdt, M. Proescholdt, Margit Proescholdt, Martin A Proescholdt, Martin A. Proescholdt, Martin Andreas Proescholdt, Martin Proescholdt, Matthias Proescholdt

198

Publications

6.1K

Citations

H-Index

107

Concepts

All Affiliations

University Hospital Regensburg University of Regensburg National Institute of Neurological Disorders and Stroke University of Cologne University Hospital Cologne

About

Martin Proescholdt is an author at University Hospital Regensburg specializing in medicine, neurology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	34	2.5K
2	Health Sciences	5	5	340
3	Social Sciences	2	2	73
4	Natural Sciences	1	1	675
5	Allergy	1	1	178

Martin Proescholdt

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles Dagmar Beier, Peter Hau, Martin Proescholdt, Cancer Research	2007	1.1K
Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer Sergey V. Ivanov, Shu‐Yuan Liao, Alla Ivanova, American Journal Of Pathology Tumor BiologyTumor MicroenvironmentBiochemistryNatural SciencesRedox Regulator	2001	675
Temozolomide Preferentially Depletes Cancer Stem Cells in Glioblastoma Dagmar Beier, Stefanie Röhrl, Deepu R. Pillai, Cancer Research	2008	289
Vascular Endothelial Growth Factor (VEGF) Modulates Vascular Permeability and Inflammation in Rat Brain Martin Proescholdt, John D. Heiss, Stuart Walbridge, Journal of Neuropathology & Experimental Neurology ImmunologyGliomaRat BrainCerebral Vascular RegulationNeuroinflammation	1999	225
Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen, Oligonucleotides	2007	217
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock, Journal of Clinical Oncology	2016	194
Sodium fluorescein–guided resection under the YELLOW 560 nm surgical microscope filter in malignant brain tumor surgery—a feasibility study Karl-Michael Schebesch, Martin Proescholdt, Julius Höhne, Acta Neurochirurgica Neuro-oncologySurgical OncologyOncologic ImagingOphthalmologyBiomedical Imaging	2013	188
Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats Martin Proescholdt, Steven Jacobson, Nancy Tresser, Journal of Neuropathology & Experimental Neurology ImmunologyPathologyNeuroinflammationInflammationAngiogenesis	2002	178
CD133 Expression and Cancer Stem Cells Predict Prognosis in High‐grade Oligodendroglial Tumors Dagmar Beier, Jörg Wischhusen, Wolfgang Dietmaier, Brain Pathology PathologyCancer BiologyGliomaFavorable PrognosisTumor Biology	2008	140
RNOP-09: Pegylated liposomal doxorubicine and prolonged temozolomide in addition to radiotherapy in newly diagnosed glioblastoma - a phase II study Christoph P. Beier, Christina Schmid, Thierry Gorlia, BMC Cancer	2009	129

Page 1